Spebrutinib (CC-292)

Ask supplier a question | View on supplier's website

Spebrutinib (CC-292, AVL-292) is a covalent, orally active, and highly selective BTK inhibitor with IC50 of <0.5 nM, displaying at least 1400-fold selectivity over the other kinases assayed. Phase 1.

Supplier	Selleck Chemicals
Product #	S7173
Sku #	S7173-10mg
Pricing	10mg, $297.00

Feedback